This site is intended for Healthcare Professionals only

Incorrect username and/or password, please try again or click to reset.

Company led medicines recall: Mawdsley-Brooks & Company Limited, Fluphenazin-neuraxpharm® D 25 & 100 mg/ml Solution for Injection, CLMR(23)A/01

2023-01-12 14:05:17 (3 year(s) ago)

Summary

Specific batches of the product are recalled as a precautionary measure due to validation tests demonstrating the leaching of filter additives that are above the acceptable limit.

Read full MHRA article

Respond to this alert

Sign up for your FREE ticket to see PharmData at the Pharmacy Show to see our latest products and features demonstrated live!